Rapid Determination of Olanzapine in Plasma by LC-ESI-MS/MS and Its Clinical Application
WEN Yu-guan1, LIAO Ri-fang2 , WANG Wei-hua1
Author information+
(1. <>Department of Clinical Pharmacology, Guangzhou Brain Hospital, Guangzhou 510370 , <> China ; 2. <>Department of Pharmacy, Second Affiliated Hospital of Sun Yat-sen University,<> Guangzhou 510120, <>China
OBJECTIVE To develop a LC-ESI-MS/MS method for olanzapine assay in plasma. METHODS Olanzapine was extracted with hexane-isoamyl alcohol. The residues were analyzed with a LC-ESI-MS/MS system (Dikma DiamonsilTM C18 column , 4.6 mm×150 mm,5 μm) with the mobile phase consisted of methanol:water with 5 mmol·L-1 ammonium formate (90∶10). A Agilent 6 410 triple quad mass spectrometer system equipped with an electrospray ionization ion-trap source was used as the detector and operated in the positive ion mode. Selected reaction monitoring(SRM) using the precursor to product ion combinations of m/z 313→256 and m/z 515.3→497.3 was performed to detect olanzapine and the internal standard, respectively. The method was used to evaluate clinical application for 36 patients after multiple oral doses of olanzapine tablets. RESULTS The average recoveries for olanzapine were 100.14%, 100.33% and 100.21%,respectively. The within-day (n=5) and between-day (n=3) precision of variation was less than 15%. The calibration curves for olanzapine had good linearity (r=0.999, n=8) within the range of 0.5~100 μg·L-1 . The limits of quantitation for olanzapine was 0.5 μg·L-1 . CONCLUSION The method provides a sensitive, accurate, precise and reliable analytical procedure for clinical monitoring of olanzapine plasma and its pharmacokinetic studies.
WEN Yu-gun;LIO Ri-fng;WNG Wei-hu .
Rapid Determination of Olanzapine in Plasma by LC-ESI-MS/MS and Its Clinical Application[J]. Chinese Pharmaceutical Journal, 2009, 44(23): 1815-1817
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] HORI H , YOSHIMURA R , YAMADA Y , et al . Effects of olanzapine on plasma levels of catecholamine metabolites,cytokines, and brain-derived neurotrophic factor in schizophrenic patients[J]. <>Int Clin Psychopharmacol , 2007 , 22(1):21-27. [2] RAGGI M A , CASAMENTI G , MANDRIOLI R , <> et al . Quantitation of olanzapine in tablets by HPLC CZE,derivative spectrometry and linear voltammetry[J]. <>J Pharm Biomed Anal , 2000 , 23(6):973-981 . [3] BERNA M , SHUGERT R , MULLEN J. Determination of olanzapine in human plasma and serum by liquid chromatography/tandem mass spectrometry[J]. J Mass Spectrom , 1998 , 33(10):1003-1008. [4] BERNA M , ACKERMANN B , RUTERBORIES K , <> et al. Determination of olanzapine in human blood by liquid chromatography-tandem mass spectrometry[J]. J Chromatogr B Analyt Technol Biomed Life Sci , 2002 , 767(1):163-168. ( 收稿日期 : 2008-12-05 )